ea0007p147 | Neuroendocrinology and behaviour | BES2004
Kind P
, Koltowska-Haggstrom M
Background:.Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) was designed for use in patients with GHD, a condition characterized amongst other things, by impairment in QoL. For use in cost-utility analysis outcomes should be measured on a scale of social preferences that assigns values of 1 and 0 to full health and dead. Condition-specific instruments may generate summary index scores but typically lack the legitimacy for use as measures of QoL ou...